Table 3

Outcome measures, assessment methods, and assessment time points of the study
Measures Assessment methods 1. Test 1 Day Pre-OP 2. Test 6-12 Wk. Post-OP 3. Test 6 Mo. Post-OP (only IG) 4. Test 9 Mo. Post-OP (only IG) 5. Test 12. Mo. Post-OP (only IG) 6. Test 18. Mo. Post-OP
15-month exercise intervention
Physical performance Spiroergometry on treadmill x x x
Incontinence Pad-Test x x x
PSA, Testosterone, Endostatin, VEGF Blood Sample x x x
Quality of Life EORTC-QLQ-C30/PR 25 x x x x x x
Erectile Dysfunction IIEF – Questionnaire x x x x x x
Physical Activity Level (MET- Score) Freiburger Questionnaire of Physical Activity x x x x x
Compliance Compliance Questionnaire x x x x x

EORTC-QLQ-C30/PR25: European Organization for Research and Treatment of Cancer- Quality of Life Questionnaire- Cancer/Prostate Cancer Module, IG: intervention group, IIEF: International Index of Erectile Function, MET: metabolic equivalent, Post-OP: after surgery/primary treatment, Pre-OP: prior to surgery/primary treatment, PSA: prostate-specific antigen, VEGF: vascular endothelial growth factor.

Zopf et al.

Zopf et al. BMC Cancer 2012 12:312   doi:10.1186/1471-2407-12-312

Open Data